Why Rocket Lab Stock Is Sinking After Hours — and What Wall Street Sees Next
Rocket Lab's shares fell 8% in after-hours trading after delaying the Neutron rocket's debut to 2027 due to manufacturing issues. Neutron is key to the company's growth plans. Despite this, Rocket Lab reported record Q2 revenue of $234M, up 62% YoY, and a $2.36B backlog. Analysts maintain a Strong Buy rating with an average price target of $104.44.
How this was made
The 30-second read
Why it matters
The delay directly caused an 8% after‑hours price drop, indicating immediate market reaction.
Market read
The news is material for traders focused on aerospace and satellite launch equities, prompting short‑term downside risk.
What to watch
The $397 M Space Force contract and the pending Iridium acquisition could provide long‑term upside despite the short‑term setback.
Background
Rocket Lab reported record Q2 revenue and a growing backlog, but the Neutron launch delay introduces near‑term execution risk.
Ticker impact
Rocket Lab shares fell 8% in after‑hours trading after the company announced a delay of the Neutron rocket launch to 2027 due to a carbon‑composite tank issue.
downward pressure as investors price in the launch delay and reduced near‑term revenue visibility
The news is the first report of a material schedule slip for a flagship product, triggered an 8% after‑hours sell‑off, and affects future contract revenue.
Market effects
Potential slowdown for the small‑sat launch market as competitors may capture contracts while Rocket Lab resolves the Neutron issue.
U.S. space‑tech investors may reassess exposure to launch‑service providers.
Limited; impact confined to Rocket Lab and its immediate supply chain.
Counterpoint
If the delay is isolated and the backlog of contracts remains solid, the stock could rebound on the strength of its record Q2 revenue and backlog.
Key entities
- companyRocket Lab
U.S. space launch services provider (NASDAQ:RKLB).
- productNeutron rocket
Rocket Lab's upcoming heavy‑lift launch vehicle.